BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1433971)

  • 1. [The interleukin-6 signal transducer, gp130, functioning in immune, hematopoietic, and neural systems].
    Taga T
    Nihon Rinsho; 1992 Aug; 50(8):1802-10. PubMed ID: 1433971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130.
    Taga T; Narazaki M; Yasukawa K; Saito T; Miki D; Hamaguchi M; Davis S; Shoyab M; Yancopoulos GD; Kishimoto T
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10998-1001. PubMed ID: 1438305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
    Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
    J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific inhibition of IL-6 signalling with monoclonal antibodies against the gp130 receptor.
    Liautard J; Sun RX; Cotte N; Gaillard JP; Mani JC; Klein B; Brochier J
    Cytokine; 1997 Apr; 9(4):233-41. PubMed ID: 9112331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokine subfamily.
    Hirano T; Matsuda T; Nakajima K
    Stem Cells; 1994 May; 12(3):262-77. PubMed ID: 8075593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6 signal transducer gp130 has specific binding sites for different cytokines as determined by antagonistic and agonistic anti-gp130 monoclonal antibodies.
    Wijdenes J; Heinrich PC; Müller-Newen G; Roche C; Gu ZJ; Clément C; Klein B
    Eur J Immunol; 1995 Dec; 25(12):3474-81. PubMed ID: 8566040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 receptor antagonists inhibit interleukin-11 biological activity.
    Sun RX; Gennaro C; Rocco S; Gu ZJ; Klein B
    Eur Cytokine Netw; 1997 Mar; 8(1):51-6. PubMed ID: 9110148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential stimulation-induced receptor localization in lipid rafts for interleukin-6 family cytokines signaling through the gp130/leukemia inhibitory factor receptor complex.
    Port MD; Gibson RM; Nathanson NM
    J Neurochem; 2007 May; 101(3):782-93. PubMed ID: 17448148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.
    Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G
    J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polarity and lipid raft association of the components of the ciliary neurotrophic factor receptor complex in Madin-Darby canine kidney cells.
    Buk DM; Waibel M; Braig C; Martens AS; Heinrich PC; Graeve L
    J Cell Sci; 2004 Apr; 117(Pt 10):2063-75. PubMed ID: 15054106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advances in interleukin-6 therapy].
    Ogata A; Nishimoto N; Yoshizaki K
    Rinsho Byori; 1999 Apr; 47(4):321-6. PubMed ID: 10340005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. gp130 and the IL-6 family of cytokines: signaling mechanisms and thrombopoietic activities.
    Nakashima K; Taga T
    Semin Hematol; 1998 Jul; 35(3):210-21. PubMed ID: 9685167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A ciliary neurotrophic factor-sensitive human myeloma cell line.
    Gu ZJ; Zhang XG; Hallet MM; Lu ZY; Wijdenes J; Rossi JF; Klein B
    Exp Hematol; 1996 Aug; 24(10):1195-200. PubMed ID: 8765494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The N-terminus of gp130 is critical for the formation of the high-affinity interleukin-6 receptor complex.
    Moritz RL; Ward LD; Tu GF; Fabri LJ; Ji H; Yasukawa K; Simpson RJ
    Growth Factors; 1999; 16(4):265-78. PubMed ID: 10427501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning of a murine IL-6 receptor-associated signal transducer, gp130, and its regulated expression in vivo.
    Saito M; Yoshida K; Hibi M; Taga T; Kishimoto T
    J Immunol; 1992 Jun; 148(12):4066-71. PubMed ID: 1602143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor.
    Nandurkar HH; Hilton DJ; Nathan P; Willson T; Nicola N; Begley CG
    Oncogene; 1996 Feb; 12(3):585-93. PubMed ID: 8637716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopathology of interleukin 6-type cytokines.
    Hawley RG
    Stem Cells; 1994; 12 Suppl 1():155-71. PubMed ID: 7696960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-11 and its receptor.
    Yang YC; Yin T
    Biofactors; 1992 Dec; 4(1):15-21. PubMed ID: 1292471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro binding of ciliary neurotrophic factor to its receptors: evidence for the formation of an IL-6-type hexameric complex.
    De Serio A; Graziani R; Laufer R; Ciliberto G; Paonessa G
    J Mol Biol; 1995 Dec; 254(5):795-800. PubMed ID: 7500350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130.
    Zhang XG; Gu JJ; Lu ZY; Yasukawa K; Yancopoulos GD; Turner K; Shoyab M; Taga T; Kishimoto T; Bataille R
    J Exp Med; 1994 Apr; 179(4):1337-42. PubMed ID: 8145045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.